Tcr2 Therapeutics Inc (TCRR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -99,807 | -72,068 | -45,824 | -21,512 | -67,124 |
| Depreciation Amortization | 2,827 | 1,976 | 1,203 | 513 | 1,592 |
| Income taxes - deferred | 99 | 105 | 63 | 36 | 131 |
| Accounts payable and accrued liabilities | -771 | 2,066 | 2,587 | 1,684 | 451 |
| Other Working Capital | -784 | 1,513 | -1,140 | -6,248 | 872 |
| Other Operating Activity | 16,833 | 8,085 | 4,169 | 1,600 | 7,339 |
| Operating Cash Flow | $-81,603 | $-58,323 | $-38,942 | $-23,927 | $-56,739 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -11,098 | -4,352 | -2,184 | -1,491 | -7,164 |
| Purchase Of Investment | -50,726 | -40,732 | -40,732 | -40,732 | -152,812 |
| Sale Of Investment | 140,622 | 140,622 | 105,518 | 59,287 | 111,041 |
| Purchase Sale Intangibles | -351 | -308 | -128 | N/A | N/A |
| Other Investing Activity | -351 | -308 | -128 | 0 | 0 |
| Investing Cash Flow | $78,447 | $95,230 | $62,474 | $17,064 | $-48,935 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,217 | 1,013 | 580 | 376 | 1,189 |
| Other Financing Activity | 130,921 | 130,994 | 131,084 | 131,166 | 133,510 |
| Financing Cash Flow | $132,138 | $132,007 | $131,664 | $131,542 | $134,699 |
| Beginning Cash Position | 94,738 | 94,738 | 94,738 | 94,738 | 65,713 |
| End Cash Position | 223,720 | 263,652 | 249,934 | 219,417 | 94,738 |
| Net Cash Flow | $128,982 | $168,914 | $155,196 | $124,679 | $29,025 |
| Free Cash Flow | |||||
| Operating Cash Flow | -81,603 | -58,323 | -38,942 | -23,927 | -56,739 |
| Capital Expenditure | -11,098 | -4,352 | -2,184 | -1,491 | -7,164 |
| Free Cash Flow | -92,701 | -62,675 | -41,126 | -25,418 | -63,903 |